Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REG1 vs Bivalirudin in PCI (REGULATE-PCI)
NCT01848106Phase 3Terminated
- Sponsor
- Regado Biosciences
- Start
- Sep 2013
- Primary completion
- Aug 2014
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 1
01
Overview
A Phase 3 trial of pegnivacogin in coronary artery disease (CAD), sponsored by Regado Biosciences. Started Sep 2013; status: terminated.
02
Drugs
pegnivacogin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01848106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848106.